We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
Macau Gaming Revenues Dip in August: Avoid These 3 Stocks
Read MoreHide Full Article
Macau, which is the world’s largest gambling hub, has witnessed decline in casino gross gaming revenue (GGR) in August. Although casinos in Macau have resumed operations following the coronavirus-induced shutdown, casino tables still remain empty. Notably, gaming revenues from the world’s largest gambling hub fell for the 11th consecutive month. Moreover, GGR plunged more than 90% for the fifth straight month.
In August, gaming revenues from Macau nosedived 95% to 1.3 billion patacas ($163.01 million) following a decline of 95% and 97% in July and June, respectively. The downside can primarily be attributed to a declining footfall. Notably, the industry has witnessed only modest increase in the number of gamblers despite easing of quarantine restrictions.
Moreover, in the first eight months of 2020, GGR fell 81.6% year over year to $36.4 billion patacas. In fact, the casino operators in Macau were already grappling with a slowdown in China, the coronavirus pandemic has only aggravated their woes. Per Macau's Statistics and Census Bureau (DSEC) in the first half of 2020, the region witnessed a decline of 83.9% in visitation to the region.
Decline in gambling revenues from Macau is likely to impact companies, including MGM Resorts International (MGM - Free Report) , Melco Resorts & Entertainment Limited (MLCO - Free Report) , Wynn Resorts, Limited (WYNN - Free Report) and Las Vegas Sands Corp. (LVS - Free Report) , which generate majority of their revenues from Macau.
Pain to Continue
Increase in travel to Macau in September is likely to boost gaming revenues. The Individual Visit Scheme (IVS) recommenced in late last month for those in the Guangdong province and Zhuhai. IVS will allow residents of mainland China to visit Macau. In 2019, approximately half of Macau visitors were from Guangdong.
However, Macau is likely to record revenue decline in the rest of the year as well. The gambling industry is also suffering in Las Vegas, which is one of the hotspots for gamblers, due to coronavirus outbreak. Although casinos in Las Vegas have resumed operations, traffic is still very low due to the safety protocols and fears related to the pandemic.
Year to date, the industry has declined 17.5%, against the S&P 500’s growth of 3.5%.
Stay Away From These Stocks
Shares of Wynn Resorts, Limited are down 37.8% year to date. In the past 30 days, estimates for the current year have been revised downward to a loss of $13.41 from a loss of $11.82. The company currently has a Zacks Rank #4 (Sell).
Shares of Las Vegas Sands have tanked 28.1% year to date. In the past 60 days, estimates for the current year have been revised downward to a loss of $1.48 from a loss of 36 cents. The company currently has a Zacks Rank #4.
Shares of Melco Resorts & Entertainment have plunged 22.3% year to date. The company, which develops, owns, and operates casino gaming and entertainment casino resort facilities in Asia through its subsidiaries, has been impacted by the deadly virus. The Zacks Rank #4 company’s earnings estimates for current year have declined to a loss of $2.35 from a loss of $1.42 in the past 30 days.
Breakout Biotech Stocks with Triple-Digit Profit Potential
The biotech sector is projected to surge beyond $775 billion by 2024 as scientists develop treatments for thousands of diseases. They’re also finding ways to edit the human genome to literally erase our vulnerability to these diseases.
Zacks has just released Century of Biology: 7 Biotech Stocks to Buy Right Now to help investors profit from 7 stocks poised for outperformance. Our recent biotech recommendations have produced gains of +50%, +83% and +164% in as little as 2 months. The stocks in this report could perform even better.
Image: Bigstock
Macau Gaming Revenues Dip in August: Avoid These 3 Stocks
Macau, which is the world’s largest gambling hub, has witnessed decline in casino gross gaming revenue (GGR) in August. Although casinos in Macau have resumed operations following the coronavirus-induced shutdown, casino tables still remain empty. Notably, gaming revenues from the world’s largest gambling hub fell for the 11th consecutive month. Moreover, GGR plunged more than 90% for the fifth straight month.
In August, gaming revenues from Macau nosedived 95% to 1.3 billion patacas ($163.01 million) following a decline of 95% and 97% in July and June, respectively. The downside can primarily be attributed to a declining footfall. Notably, the industry has witnessed only modest increase in the number of gamblers despite easing of quarantine restrictions.
Moreover, in the first eight months of 2020, GGR fell 81.6% year over year to $36.4 billion patacas. In fact, the casino operators in Macau were already grappling with a slowdown in China, the coronavirus pandemic has only aggravated their woes. Per Macau's Statistics and Census Bureau (DSEC) in the first half of 2020, the region witnessed a decline of 83.9% in visitation to the region.
Decline in gambling revenues from Macau is likely to impact companies, including MGM Resorts International (MGM - Free Report) , Melco Resorts & Entertainment Limited (MLCO - Free Report) , Wynn Resorts, Limited (WYNN - Free Report) and Las Vegas Sands Corp. (LVS - Free Report) , which generate majority of their revenues from Macau.
Pain to Continue
Increase in travel to Macau in September is likely to boost gaming revenues. The Individual Visit Scheme (IVS) recommenced in late last month for those in the Guangdong province and Zhuhai. IVS will allow residents of mainland China to visit Macau. In 2019, approximately half of Macau visitors were from Guangdong.
However, Macau is likely to record revenue decline in the rest of the year as well. The gambling industry is also suffering in Las Vegas, which is one of the hotspots for gamblers, due to coronavirus outbreak. Although casinos in Las Vegas have resumed operations, traffic is still very low due to the safety protocols and fears related to the pandemic.
Year to date, the industry has declined 17.5%, against the S&P 500’s growth of 3.5%.
Stay Away From These Stocks
Shares of Wynn Resorts, Limited are down 37.8% year to date. In the past 30 days, estimates for the current year have been revised downward to a loss of $13.41 from a loss of $11.82. The company currently has a Zacks Rank #4 (Sell).
Shares of Las Vegas Sands have tanked 28.1% year to date. In the past 60 days, estimates for the current year have been revised downward to a loss of $1.48 from a loss of 36 cents. The company currently has a Zacks Rank #4.
Shares of Melco Resorts & Entertainment have plunged 22.3% year to date. The company, which develops, owns, and operates casino gaming and entertainment casino resort facilities in Asia through its subsidiaries, has been impacted by the deadly virus. The Zacks Rank #4 company’s earnings estimates for current year have declined to a loss of $2.35 from a loss of $1.42 in the past 30 days.
You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here.
Breakout Biotech Stocks with Triple-Digit Profit Potential
The biotech sector is projected to surge beyond $775 billion by 2024 as scientists develop treatments for thousands of diseases. They’re also finding ways to edit the human genome to literally erase our vulnerability to these diseases.
Zacks has just released Century of Biology: 7 Biotech Stocks to Buy Right Now to help investors profit from 7 stocks poised for outperformance. Our recent biotech recommendations have produced gains of +50%, +83% and +164% in as little as 2 months. The stocks in this report could perform even better.
See these 7 breakthrough stocks now>>